Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value: $1.878B (100.0% shares, 0.0% debt)

Holdings (36)

— ABIOMED INC 11.9%
Value $224M Shares 689,550 Share Price $325.04 Est. Cost/Share $32.04 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 11.6%
Value $218M Shares 2,559,733 Share Price $85.15 * Est. Cost/Share $79.79 Unrealized @ Report Date +19.2%
UTHR UNITED THERAPEUTICS CORP DEL 9.5%
Value $178M Shares 1,632,025 Share Price $108.90 * Est. Cost/Share $88.73 Unrealized @ Report Date +30.7%
STAA STAAR SURGICAL CO 7.0%
Value $132M Shares 4,147,988 Share Price $31.91 * Est. Cost/Share $12.68 Unrealized @ Report Date +207.3%
— ALEXION PHARMACEUTICALS INC 6.2%
Value $117M Shares 1,204,328 Share Price $97.36 Est. Cost/Share $121.26 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 5.8%
Value $109M Shares 4,155,670 Share Price $26.13 * Est. Cost/Share $8.70 Unrealized @ Report Date +170.2%
INSM INSMED INC 5.3%
Value $100M Shares 7,653,617 Share Price $13.12 * Est. Cost/Share $16.83 Unrealized @ Report Date -5.2%
— CLOVIS ONCOLOGY INC 5.0%
Value $94.1M Shares 5,239,304 Share Price $17.96 Est. Cost/Share $51.30 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 4.3%
Value $81.52M Shares 850,977 Share Price $95.79 Est. Cost/Share $48.62 Unrealized @ Report Date —
— WRIGHT MED GROUP N V 4.0%
Value $75.44M Shares 2,771,394 Share Price $27.22 Est. Cost/Share $23.42 Unrealized @ Report Date —
— IMMUNOMEDICS INC 3.9%
Value $74.01M Shares 5,186,255 Share Price $14.27 Est. Cost/Share $12.01 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 3.8%
Value $70.91M Shares 7,401,321 Share Price $9.58 * Est. Cost/Share $7.28 Unrealized @ Report Date +51.0%
— AMAG PHARMACEUTICALS INC 2.7%
Value $51.35M Shares 3,380,506 Share Price $15.19 Est. Cost/Share $29.26 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 2.3%
Value $43.9M Shares 4,685,352 Share Price $9.37 Est. Cost/Share $18.85 Unrealized @ Report Date —
— EPIZYME INC 2.3%
Value $42.72M Shares 6,935,074 Share Price $6.16 Est. Cost/Share $15.12 Unrealized @ Report Date —
— CELGENE CORP 1.8%
Value $34.14M Shares 532,667 Share Price $64.09 Est. Cost/Share $89.02 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 1.8%
Value $33.19M Shares 1,387,589 Share Price $23.92 Est. Cost/Share $23.79 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 1.7%
Value $32.84M Shares 156,823 Share Price $209.43 * Est. Cost/Share $107.51 Unrealized @ Report Date +135.0%
ACAD ACADIA PHARMACEUTICALS INC 1.7%
Value $32.76M Shares 2,026,063 Share Price $16.17 * Est. Cost/Share $27.84 Unrealized @ Report Date -30.2%
PBYI PUMA BIOTECHNOLOGY INC 1.3%
Value $23.6M Shares 1,159,900 Share Price $20.35 * Est. Cost/Share $30.01 Unrealized @ Report Date 0.0%
— MOMENTA PHARMACEUTICALS INC 1.1%
Value $20.33M Shares 1,841,613 Share Price $11.04 Est. Cost/Share $14.12 Unrealized @ Report Date —
EXAS EXACT SCIENCES CORP 1.1%
Value $19.87M Shares 314,889 Share Price $63.10 * Est. Cost/Share $13.61 Unrealized @ Report Date +404.1%
— ALDER BIOPHARMACEUTICALS INC 1.0%
Value $19.08M Shares 1,861,630 Share Price $10.25 Est. Cost/Share $11.48 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 0.6%
Value $11.42M Shares 1,108,510 Share Price $10.30 * Est. Cost/Share $32.98 Unrealized @ Report Date -64.0%
GILD GILEAD SCIENCES INC 0.6%
Value $11M Shares 175,900 Share Price $62.55 * Est. Cost/Share $62.02 Unrealized @ Report Date -14.5%
— RIGEL PHARMACEUTICALS INC 0.5%
Value $9.168M Shares 3,985,945 Share Price $2.30 Est. Cost/Share $3.40 Unrealized @ Report Date —
— SHIRE PLC 0.4%
Value $8.343M Shares 47,938 Share Price $174.04 Est. Cost/Share $197.13 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.3%
Value $5.355M Shares 500,913 Share Price $10.69 Est. Cost/Share $5.39 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.1%
Value $2.164M Shares 3,013,793 Share Price $0.72 Est. Cost/Share $4.88 Unrealized @ Report Date —
— ZOGENIX INC 0.1%
Value $1.076M Shares 29,500 Share Price $36.47 Est. Cost/Share $13.36 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.0%
Value $782K Shares 123,686 Share Price $6.32 * Est. Cost/Share $6.71 Unrealized @ Report Date +9.3%
— SUNESIS PHARMACEUTICALS INC 0.0%
Value $483K Shares 1,162,473 Share Price $0.42 Est. Cost/Share $4.37 Unrealized @ Report Date —
— IDERA PHARMACEUTICALS INC 0.0%
Value $213K Shares 77,044 Share Price $2.76 Est. Cost/Share $8.90 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.0%
Value $205K Shares 247,000 Share Price $0.83 Est. Cost/Share $2.60 Unrealized @ Report Date —
— MELINTA THERAPEUTICS INC 0.0%
Value $40,000 Shares 50,689 Share Price $0.79 Est. Cost/Share $15.80 Unrealized @ Report Date —
— HISTOGENICS CORP 0.0%
Value $27,000 Shares 302,922 Share Price $0.09 Est. Cost/Share $11.00 Unrealized @ Report Date —